Analysis

Research Topics
Research Categories
Life Sciences and Public Health
  • Biotechnology
  • Biowarfare
  • COVID 19
  • Life Sciences
  • Public Health
  • Genomics
Technology and POLICY
  • Data Protection
  • High Tech Geopolitics
  • Platform Regulation
  • Information Disorder
  • Networked Protests
  • Artificial Intelligence
  • Social Media
  • Technology
Foreign Affairs, Defence and Security
  • Defence
  • China
  • Foreign Policy
  • National Security
  • Nuclear Strategy
  • Europe
  • West Asia
  • Space Policy
  • Space Strategy
  • USA
  • Energy
  • Communications
  • Indo-Pacific
  • India's Neighbourhood
  • Maritime
  • Subsurface
  • World Order
  • Military
  • PLA
  • Semiconductors
Public Affairs and Governance
  • Economy
  • Governance
  • Markets
  • Public Finance
  • Labour
  • Investment
  • Policy Discussion
  • Banking
  • Regulation
  • Ideas for India
  • COVID 19

Omicron: Is India testing enough?

With the onslaught of the third wave, low testing rates have become a point of concern. With positivity rates touching 30 per cent in some cities as against the World Health Organisation (WHO)’s recommended five per cent, we do not see a proportional rise in the number of cases. This low number...

10 Mistakes India Needs To Avoid To Better Deal With Its Third Covid-19 Wave

With an exponential rise in the number of cases, it is certain that the next few weeks are going to be challenging and will put our medical readiness and health resources to the test. If we are to avoid a repeat of the devastation of the past two waves, but especially...

Who’s Stopping An Indian Medical Service?

The need for an Indian Medical Service Cadre has been highlighted and discussed multiple times in recent years. The Covid-19 pandemic has reinforced the urgent importance of the cadre. An Indian Medical Service, comparable to the IAS, IPS and IFS, is necessary to administrate and encourage the delivery of healthcare services...

Omicron: Clinically Milder But Potentially Deadlier

There has been a sudden surge in Covid cases across the country in the past few days. This increase can be attributed to the newest Covid-19 variant: Omicron. Ignorance, misconception, and a delay in response could result in India’s even more fatal third wave. With India still reeling from the effects...

Takshashila Issue Paper – Tackling New COVID-19 Variants

Download the Discussion Document in PDF Executive Summary New variants of SARS-CoV-2 are being routinely identified and evaluated. For example, a new variant named AY.4.2 was detected in a few Indian samples in early November. The clinical manifestation of the former is similar to previous variants; however, its secondary infection...

Omicron Scare – Why International Travel Ban Will Do India More Harm than Good

The possibility of another disastrous wave in the country has increased with the discovery of a new SARS-CoV-2 variant, Omicron, and two such cases being detected in Karnataka. This has come along with the Union government issuing new travel guidelines on November 30. A likelihood of the country putting a...

Effective communication about COVID-19 could save lives – but India’s strategy has been flawed

Over the past few decades, public health emergencies across the globe have shown us that a timely and efficient risk communication plan could help in minimising fatalities and managing situations on the ground. In unprecedented circumstances such as the Covid-19 pandemic, implementing effective communication methods becomes even more necessary. At...

Why India shouldn’t allow COVID-19 booster dose

The Delta variant caused a fresh wave of Covid-19 infections worldwide, aggravating the global public health catastrophe. The currently available Covid-19 vaccines are effective against the Delta variant, which prompted researchers to evaluate whether booster doses for vaccinated people are necessary and when they should be given. The objective of...

Takshashila Discussion Document – Vaccine Diplomacy Framework for India

Executive Summary This document provides a framework to broaden the scope of India’s vaccine diplomacy during and after the COVID-19 pandemic. The pandemic has highlighted the inequality of vaccine distribution around the world, giving India the opportunity to step into the vacuum left by traditional global leaders. This framework can...

COVID-19 outbreak underlines need for India to develop its own epidemic intelligence service

Recently both WHO and the US have announced the establishment of centres to monitor the emergence and spread of new diseases. WHO’s new Hub for Pandemic and Epidemic Intelligence in Germany, and the US’ Center for Forecasting and Outbreak Analytics under the CDC system will gather data on emerging diseases and forecast their...
1 2 3 15